Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Pamela B Arenella"'
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0124613 (2015)
BackgroundNaltrexone is a front-line treatment for alcohol use disorders, but its efficacy is limited by poor medication adherence. This randomized controlled trial evaluated whether a mobile health intervention could improve naltrexone adherence.Met
Externí odkaz:
https://doaj.org/article/1af021f06f8044c7b8de8e084fca18e3
Functional network connectivity predicts treatment outcome during treatment of nicotine use disorder
Autor:
Eric D. Claus, Vince D. Calhoun, Rae A. Littlewood, Srinivas Rachakonda, Kent E. Hutchison, Pamela B. Arenella, Jessica Mickey, Claire E. Wilcox
Publikováno v:
Psychiatry research. Neuroimaging. 265
Altered resting state functional connectivity (rsFC) and functional network connectivity (FNC), which is a measure of coherence between brain networks, may be associated with nicotine use disorder (NUD). We hypothesized that higher connectivity betwe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72ee27b59a6045185adc4d88213ac49d
https://pubmed.ncbi.nlm.nih.gov/28525877
https://pubmed.ncbi.nlm.nih.gov/28525877
Autor:
Pamela B. Arenella, Howard S. Vogel, Michael P. Bogenschutz, Joseph Nowinski, Samara L. Rice, Donald Hume, J. Scott Tonigan
Publikováno v:
Journal of Substance Abuse Treatment. 46:403-411
There are few clinical trials of 12-step treatments for individuals with serious mental illness and alcohol or drug dependence. This randomized trial assessed the effects of adding a 12-session 12-step facilitation therapy (TSF), adapted from that us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f571b415aef7c71db55228a4c1225f0a
https://doi.org/10.1016/j.jsat.2013.12.009
https://doi.org/10.1016/j.jsat.2013.12.009
Autor:
Claire E, Wilcox, Eric D, Claus, Vince D, Calhoun, Srinivas, Rachakonda, Rae A, Littlewood, Jessica, Mickey, Pamela B, Arenella, Natalie, Goodreau, Kent E, Hutchison
Publikováno v:
Addiction biology. 23(1)
Identifying predictors of treatment outcome for nicotine use disorders (NUDs) may help improve efficacy of established treatments, like varenicline. Brain reactivity to drug stimuli predicts relapse risk in nicotine and other substance use disorders
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::506f1bbee2eb14c789e2b0f50710cbd2
https://pubmed.ncbi.nlm.nih.gov/28231626
https://pubmed.ncbi.nlm.nih.gov/28231626
Autor:
Angela D. Bryan, Jessica Mickey, Kent E. Hutchison, Rae A. Littlewood, Claire E. Wilcox, Eric D. Claus, Pamela B. Arenella
Publikováno v:
Psychopharmacology. 234(23-24)
Varenicline has gained a reputation as the optimal intervention for treatment resistant smokers, yet more than half of those who try it do not succeed. To better understand individual differences in the effectiveness of varenicline, this study evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::286a94266d9a3825a03f429d749ba66a
https://pubmed.ncbi.nlm.nih.gov/28889258
https://pubmed.ncbi.nlm.nih.gov/28889258
Autor:
Cynthia M. A. Geppert, Jeffrey Katzman, Julie Kilpatrick, David A. Graeber, Pamela B. Arenella
Publikováno v:
Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry. 40(1)
The young psychiatrist is learning to cope with such remarks. He feels his internal shield go up and a sense of separation arise. Though he has masked his feelings of awkwardness with bantering, he carries resentment for his membership in a residency
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cd6291e30b6e5f799716951523daf80
https://pubmed.ncbi.nlm.nih.gov/26634276
https://pubmed.ncbi.nlm.nih.gov/26634276
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0124613 (2015)
PLoS ONE
PLoS ONE
BackgroundNaltrexone is a front-line treatment for alcohol use disorders, but its efficacy is limited by poor medication adherence. This randomized controlled trial evaluated whether a mobile health intervention could improve naltrexone adherence.Met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::666ed75406edaddeccd0a964e1e13341
https://doaj.org/article/1af021f06f8044c7b8de8e084fca18e3
https://doaj.org/article/1af021f06f8044c7b8de8e084fca18e3
Autor:
Sarah W. Feldstein Ewing, Hollis C. Karoly, Kent E. Hutchison, Pamela B. Arenella, Eric D. Claus, Michael P. Bogenschutz, Rae A. Littlewood, Angela D. Bryan
Publikováno v:
Psychopharmacology. 232(7)
It is well established that the rewarding effects of alcohol are modulated by the mesolimbic dopaminergic system. Olanzapine, a D2 dopamine antagonist, has been shown to reduce alcohol craving and consumption. To clarify whether olanzapine has clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d5c4f814cb9e73b1dd3799e2341ba1f
https://pubmed.ncbi.nlm.nih.gov/25304864
https://pubmed.ncbi.nlm.nih.gov/25304864